Richard J. Hart - 02 Jun 2021 Form 4 Insider Report for Altair Engineering Inc. (ALTR)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
04 Jun 2021, 07:56:30 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Raoul Maitra, attorney-in-fact for Richard J. Hart

Key filing fact

Richard J. Hart filed Form 4 for Altair Engineering Inc. (ALTR) on 04 Jun 2021.

Key facts

  • This page summarizes Richard J. Hart's Form 4 filing for Altair Engineering Inc. (ALTR).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Jun 2021, 07:56.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALTR transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+2,987
Change %
+33%
Price
$0.000000
Shares after
11,987
Date
02 Jun 2021
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On June 2, 2021, the Reporting Person was granted 2,987 Class A Common Stock restricted stock units, which will vest on June 2, 2022 Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock.

Footnote F2

Consists of 4,487 Class A Common Stock restricted stock units that are unvested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .